{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T20:36:53Z","timestamp":1726000613868},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"876","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,10,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned to have been the foundation of the pharmaceutical industry. For most of the time since then it has been used for the relief of pain and fever. The modern phase of aspirin use commenced with the reporting in 1974 of a randomised controlled trial in the secondary prevention of death by low-dose aspirin given to patients who had suffered a myocardial infarct. Reports of other trials followed and an overview of the first six trials was presented to the inaugural meeting of the Society for Clinical Trials in Philadelphia in 1980. There have been two further major overviews and the most recent, based on 145 trials, established that low-dose aspirin reduces vascular events by around one third.<\/jats:p>\n               <jats:p>It has been estimated that, used appropriately, aspirin could prevent 100,000 premature deaths each year worldwide, at a cost of about 250 Pounds ($400) per life saved, and about 80 Pounds ($130) per cardiovascular event prevented. The evidence indicates that it is seriously underused at present. The aspirin story continues and trials are in progress to test other possible uses of aspirin, in vascular dementia, colorectal cancer, and cataract.<\/jats:p>","DOI":"10.1136\/pgmj.74.876.587","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:49:00Z","timestamp":1230587340000},"page":"587-591","source":"Crossref","is-referenced-by-count":6,"title":["Platelets, aspirin, and cardiovascular disease"],"prefix":"10.1093","volume":"74","author":[{"given":"P C","family":"Elwood","sequence":"first","affiliation":[{"name":"MRC Epidemiology Unit, Llandough Hospital , Penarth, South Glamorgan CF64 2XW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Hughes","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Llandough Hospital , Penarth, South Glamorgan CF64 2XW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"O'Brien","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Llandough Hospital , Penarth, South Glamorgan CF64 2XW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1998,10,1]]},"reference":[{"key":"ref_1","article-title":"This is equivalent to about \u00a380 ($130) per cardiovascular event prevented, making aspirin the most cost-effective drug available today. Concern has, however, been expressed that aspirin taking after infarction, and knowledge amongst doctors of the possible benefits of aspirin, is very much less than optimal.23 Use of the drug has probably been limited by the fact that, outside Germany, it carries no patent, it is commonly available, inexpensive and makes no profit","year":"1994","unstructured":"January 1994). This is equivalent to about \u00a380 ($130) per cardiovascular event prevented, making aspirin the most cost-effective drug available today. Concern has, however, been expressed that aspirin taking after infarction, and knowledge amongst doctors of the possible benefits of aspirin, is very much less than optimal.23 Use of the drug has probably been limited by the fact that, outside Germany, it carries no patent, it is commonly available, inexpensive and makes no profit."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM199610103351517","article-title":"Aspirin and coronary disease","volume":"335","author":"Vogel, R.A.","year":"1996","unstructured":"Vogel RA. Aspirin and coronary disease. N Engl J Med 1996;335:1161-2.","journal-title":"N Engl J Med"},{"key":"ref_3","first-page":"417","article-title":"Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?","volume":"47","author":"McCallum, A.K.; Whincup, P.H.; Morris, R.W.; Thompson, A.; Walker, M.; Ebrahim, S.","year":"1997","unstructured":"McCallum AK, Whincup PH, Morris RW, Thompson A, Walker M, Ebrahim S. Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed? Br J Gen Pract 1997;47:417-21.","journal-title":"Br J Gen Pract"},{"key":"ref_4","first-page":"366","article-title":"De l'origine des globules du sang, de leur mode de formation et de leur fin","volume":"14","author":"Donne, A.","year":"1842","unstructured":"Donne A. De l'origine des globules du sang, de leur mode de formation et de leur fin. Compt RendAcad Sci 1842;14:366-8.","journal-title":"Compt RendAcad Sci"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood.V3.10.1073.1073","article-title":"Historical notes on blood platelets","volume":"3","author":"Tocantins, L.M.","year":"1948","unstructured":"Tocantins LM. Historical notes on blood platelets. Blood 1948;3:1073-82.","journal-title":"Blood"},{"key":"ref_6","first-page":"3","article-title":"The blood platelets - past, present and future. In: Henry Ford Hospital International Symposium Blood Platelets","author":"Tocantins, L.M.","year":"1960","unstructured":"Tocantins LM. The blood platelets - past, present and future. In: Henry Ford Hospital International Symposium Blood Platelets. London: Churchill Ltd, 1960; pp 3-6."},{"key":"ref_7","first-page":"692","article-title":"Recherches sur l'evolution des hematies dans le sang de l'homme et des vertebres","volume":"5","author":"Hayem, G.","year":"1878","unstructured":"Hayem G. Recherches sur l'evolution des hematies dans le sang de l'homme et des vertebres. Arch Phys Norm Pathol 1878;5:692-734.","journal-title":"Arch Phys Norm Pathol"},{"issue":"43","key":"ref_8","first-page":"703","volume":"1883","author":"Osler, W.","unstructured":"Osler W. Editorial. Med News 1883;43:703.","journal-title":"Editorial. Med News"},{"key":"ref_9","first-page":"391","article-title":"An account of certain organisms occurring","volume-title":"the liquour sanguinis. Proc R Soc Lond","volume":"22","author":"Osler, W.","year":"1874","unstructured":"Osler W. An account of certain organisms occurring in the liquour sanguinis. Proc R Soc Lond 1874;22:391-462."},{"issue":"90","key":"ref_10","first-page":"261","article-title":"Uber einen neuen frombes tandeil des blutes und dessen rolle bei der thrombose und der blutgerinnung","volume":"1882","author":"Bizzozero, G.","unstructured":"Bizzozero G. Uber einen neuen frombes tandeil des blutes und dessen rolle bei der thrombose und der blutgerinnung. Virchows Arch Pathol Anat 1882;90:261-332.","journal-title":"Virchows Arch Pathol Anat"},{"issue":"103","key":"ref_11","first-page":"39","article-title":"Experimentelle untersuchungen uber thrombose","volume":"1886","author":"Eberth, J.C.; Schimmelbusch, C.","unstructured":"Eberth JC, Schimmelbusch C. Experimentelle untersuchungen uber thrombose. Virchows Arch PatholAnat 1886;103:39-87.","journal-title":"Virchows Arch PatholAnat"},{"key":"ref_12","first-page":"3","article-title":"Change in platelet adenosine triphosphate concentration and distribution during viscous metamorphosis and clot retraction. In: Henry Ford Hospital International Symposium Blood Platelets","author":"Zucker, M.B.; Borelli, J.","year":"1960","unstructured":"Zucker MB, Borelli J Change in platelet adenosine triphosphate concentration and distribution during viscous metamorphosis and clot retraction. In: Henry Ford Hospital International Symposium Blood Platelets. London: Churchill Ltd, 1960; pp 3-6."},{"key":"ref_13","first-page":"174","article-title":"Blutbefund und culterversuche in einem fall von purpura hamorrhagica. Zentralbl Pathol Pathol Anat 1893; iv","author":"Denys, J.","unstructured":"Denys J. Blutbefund und culterversuche in einem fall von purpura hamorrhagica. Zentralbl Pathol Pathol Anat 1893;iv: 174-81."},{"issue":"10","key":"ref_14","first-page":"445","article-title":"The pathogenesis of purpura hemorrhagica with especial reference to the part played by blood-platelets","volume":"1912","author":"Duke, W.W.","unstructured":"Duke WW. The pathogenesis of purpura hemorrhagica with especial reference to the part played by blood-platelets. Arch Intern Med 1912;10:445-69.","journal-title":"Arch Intern Med"},{"issue":"154","key":"ref_15","first-page":"643","article-title":"The origin and nature ofblood plates","volume":"1906","author":"Wright, T.","unstructured":"Wright T. The origin and nature ofblood plates. Bost Med SurgJ 1906;154:643-5.","journal-title":"Bost Med SurgJ"},{"key":"ref_16","article-title":"Pathological anatomy, Vols i-iv","author":"Rockitansky, C.","year":"1854","unstructured":"Rockitansky C. Pathological anatomy, Vols i-iv. London: Sydenham Soc, 1854."},{"issue":"55","key":"ref_17","first-page":"1185","article-title":"The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relived by transfusion","volume":"1910","author":"Duke, W.W.","unstructured":"Duke WW. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relived by transfusion. JAMA 1910;55:1185-92.","journal-title":"JAMA"},{"key":"ref_18","first-page":"161","article-title":"The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants","volume":"54","author":"Wright, H.P.","year":"1941","unstructured":"Wright HP. The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. J Pathol Bacteriol 1941;54: 161-8.","journal-title":"J Pathol Bacteriol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jcp.15.5.452","article-title":"Platelet aggregation. Part II Some results from a new method of study","volume":"15","author":"O'Brien, JR","year":"1962","unstructured":"O'Brien JR. Platelet aggregation. Part II Some results from a new method of study.J Clin Pathol 1962;15:452-5.","journal-title":"J Clin Pathol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","author":"Born, G.V.R.","year":"1962","unstructured":"Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-9.","journal-title":"Nature"},{"issue":"2","key":"ref_21","first-page":"91","volume":"1961","author":"Annotation, O'Brien JR.","unstructured":"O'Brien JR. Annotation. Lancet 1961;2:91.","journal-title":"Lancet"},{"key":"ref_22","first-page":"402","article-title":"Hemorrhagic diathesis with increased capillary fragility caused by salicylate therapy","author":"Frick, P.G.","year":"1956","unstructured":"Frick PG. Hemorrhagic diathesis with increased capillary fragility caused by salicylate therapy. Am JMed Sci 1956;April:402-6.","journal-title":"Am JMed Sci"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(00)78970-7","article-title":"Gastropic observation of the effect of aspirin and certain other substances on the stomach","volume":"ii:","author":"Douthwaite, A.H.; Lintott, G.A.M.","year":"1938","unstructured":"Douthwaite AH, Lintott GAM. Gastropic observation of the effect of aspirin and certain other substances on the stomach. Lancet 1938; ii: 1222-5.","journal-title":"Lancet"},{"issue":"14","key":"ref_24","first-page":"140","article-title":"The adhesiveness of native platelets and its prevention","volume":"1961","author":"O'Brien, JR","unstructured":"O'Brien JR. The adhesiveness of native platelets and its prevention. Clin Pathol 1961;14:140-9.","journal-title":"Clin Pathol"},{"key":"ref_25","first-page":"51","article-title":"The adhesiveness of native platelets: some anti-adhesive drugs and their","volume-title":"mode of action. Proc VIII Congress Eur Soc Haematol 1961","author":"O'Brien, JR","unstructured":"O'Brien JR. The adhesiveness of native platelets: some anti-adhesive drugs and their mode of action. Proc VIII Congress Eur Soc Haematol 1961; pp 51-6."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0038-1654966","article-title":"An in vivo trial of an anti-adhesive drug","volume":"9","author":"O'Brien, JR","year":"1963","unstructured":"O'Brien JR. An in vivo trial of an anti-adhesive drug. Thromb Diath Haemost 1963;9:120-5.","journal-title":"Thromb Diath Haemost"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V24.3.309.309","article-title":"The mechanisms and preventions of platelet adhesion and aggregation considered in relation to arterial thrombosis","volume":"24","author":"O'Brien, JR","year":"1964","unstructured":"O'Brien JR. The mechanisms and preventions of platelet adhesion and aggregation considered in relation to arterial thrombosis. Blood 1964;24: 309-14.","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(66)92227-6","article-title":"Acetylsalicylic acid and haemorrhage","volume":"ii:","author":"Quick, A.J.","year":"1966","unstructured":"Quick AJ. Acetylsalicylic acid and haemorrhage. Lancet 1966;ii: 1134-5.","journal-title":"Lancet"},{"key":"ref_29","first-page":"768","article-title":"Acetylsalicylic acid as a cause of pancytopenia from bone marrow damage","volume":"ii:","author":"Wjinja, L.; Snijder, J.A.M.; Nieweg, H.O.","year":"1966","unstructured":"Wjinja L, Snijder JAM, Nieweg HO.Acetylsalicylic acid as a cause of pancytopenia from bone marrow damage Lancet 1966;ii:768-9.","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(67)91342-6","article-title":"Acetylsalicylic acid and platelet stickiness","volume":"1","author":"Morris, C.D.W.","year":"1967","unstructured":"Morris CDW. Acetylsalicylic acid and platelet stickiness. Lancet 1967;1:279-80.","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(67)91021-5","article-title":"Spontaneous bruising","volume":"ii:","author":"Evans, G.; Mustard, J.F.; Packham, M.","year":"1967","unstructured":"Evans G, Mustard JF, Packham M. Spontaneous bruising. Lancet 1967;ii:724-5.","journal-title":"Lancet"},{"key":"ref_32","first-page":"547","article-title":"Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by","volume-title":"acetylsalicylic acid ingestion. Proc Soc Exp Biol Med 1968","volume":"127","author":"Zucker, M.B.; Peterson, J.","unstructured":"Zucker MB, Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med 1968;127: 547-51."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(71)92237-9","article-title":"Two in-vivo studies comparing high and low aspirin dosage","volume":"i:","author":"O'Brien, JR","year":"1971","unstructured":"O'Brien JR. Two in-vivo studies comparing high and low aspirin dosage. Lancet 1971;i:399-400.","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(68)92228-9","article-title":"Effects of salicylates on human platelets","volume":"i:","author":"O'Brien, JR","year":"1968","unstructured":"O'Brien JR. Effects of salicylates on human platelets. Lancet 1968;i:779-83.","journal-title":"Lancet"},{"key":"ref_35","first-page":"2169","article-title":"The effect of salicylates on lets in man. J the hemostatic properties of plateClin Invest","volume":"47","author":"Weiss, H.J.; Aledort, L.M.; Kochwa, S.","year":"1968","unstructured":"Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on lets in man. J the hemostatic properties of plateClin Invest 1968;47:2169-80."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(68)92594-4","article-title":"Aspirin and platelet aggregation","volume":"i:","author":"O'Brien, JR","year":"1968","unstructured":"O'Brien JR. Aspirin and platelet aggregation. Lancet 1968;i:204-5.","journal-title":"Lancet"},{"key":"ref_37","first-page":"463","article-title":"Platelet function studies in human being receiving 300 mg of aspirin per day","volume":"75","author":"Stuart, R.K.","year":"1970","unstructured":"Stuart RK. Platelet function studies in human being receiving 300 mg of aspirin per day. J Lab Clin Med 1970;75:463-71.","journal-title":"J Lab Clin Med"},{"key":"ref_38","first-page":"95","article-title":"Acetylsalicylic acid; possible preventive of coronary thrombosis","volume":"4","author":"Craven, L.L.","year":"1950","unstructured":"Craven LL. Acetylsalicylic acid; possible preventive of coronary thrombosis. Ann West Med Surg 1950;4:95-9.","journal-title":"Ann West Med Surg"},{"key":"ref_39","first-page":"213","article-title":"Prevention of coronary and cerebral thrombosis","volume":"78","author":"Craven, L.L.","year":"1956","unstructured":"Craven LL. Prevention of coronary and cerebral thrombosis. Miss Val Med J 1956;78:213-5.","journal-title":"Miss Val Med J"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.1.5905.436","article-title":"A randomised controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction","volume":"1","author":"Elwood, P.C.; Cochrane, A.L.; Burr, M.L.","year":"1974","unstructured":"Elwood PC, Cochrane AL, Burr ML, et al. A randomised controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. BMJ 1974;1:436-40.","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0021-9681(76)90020-5","article-title":"Coronary Drug Project Research Group. Aspirin in coronary heart disease","volume":"29","year":"1976","unstructured":"Coronary Drug Project Research Group. Aspirin in coronary heart disease. J Chron Dis 1976; 29:625-42.","journal-title":"J Chron Dis"},{"key":"ref_42","first-page":"325","article-title":"Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenproumon","volume":"9","author":"Breddin, K.; Loew, D.; Lechner, K.","year":"1980","unstructured":"Breddin K, Loew D, Lechner K, et al. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenproumon. Haemostasis 1980;9:325-44.","journal-title":"Haemostasis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(79)92808-3","article-title":"Aspirin and secondary mortality after myocardial infarction","volume":"ii:","author":"Elwood, P.C.; Sweetnam, P.M.","year":"1979","unstructured":"Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction. Lancet 1979;ii: 1313-5.","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.1980.03300330019023","article-title":"Aspirin Myocardial Infarction Study Research Group. A randomised in persons recovered controlled trial of from myocardial aspirin infarction","volume":"243","year":"1980","unstructured":"Aspirin Myocardial Infarction Study Research Group. A randomised in persons recovered controlled trial of from myocardial aspirin infarction. JAMA 1980;243:661-9.","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Steering Committee of the Physicians' Health Research Group. Final report on the aspirin component of the ongoing physicians' health study","volume":"321","year":"1989","unstructured":"Steering Committee of the Physicians' Health Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl JMed 1989;321:129-35.","journal-title":"N Engl JMed"},{"key":"ref_46","article-title":"The health of the nation: assessing the options: CHDIStroke. Target effectiveness and cost-effectiveness of interventions to reduce coronary heart disease and stroke mortality","author":"NHS Executive","year":"1995","unstructured":"NHS Executive. The health of the nation: assessing the options: CHDIStroke. Target effectiveness and cost-effectiveness of interventions to reduce coronary heart disease and stroke mortality. London: Department of Health, 1995."},{"key":"ref_47","first-page":"555","article-title":"Role of the general practitioner in managing patients with myocardial infarction","author":"British Heart Foundation Working Group","year":"1989","unstructured":"British Heart Foundation Working Group. Role of the general practitioner in managing patients with myocardial infarction. BMJ 1989;555-7.","journal-title":"BMJ"},{"key":"ref_48","first-page":"619","article-title":"Low-Dose Aspirin Study in Pregnancy) Collaborative Group. A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"i:","author":"CLASP (Collaborative","year":"1994","unstructured":"CLASP (Collaborative Low-Dose Aspirin Study in Pregnancy) Collaborative Group. A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;i:619-29.","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(92)92177-H","article-title":"Preventible senility: a call for action against the vascular dementias","volume":"340","author":"Hachinsky, V.","year":"1992","unstructured":"Hachinsky V. Preventible senility: a call for action against the vascular dementias. Lancet 1992;340:645-7.","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.1989.tb05688.x","article-title":"A randomised clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study","volume":"37","author":"Meyer, J.S.; Rogers, R.L.; McClintic, K.; Mortel, K.F.; Lotfi, J.","year":"1989","unstructured":"Meyer JS, Rogers RL, McClintic K, Mortel KF, Lotfi J. A randomised clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. JAm Geriat Soc 1989;37:549-55.","journal-title":"JAm Geriat Soc"},{"key":"ref_51","first-page":"269","article-title":"Is there any evidence for a protective effect of anti-thrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings","volume":"62","author":"Richards, M.; Meade, T.W.; Peart, S.; Brennan, P.J.; Mann, A.H.","year":"1997","unstructured":"Richards M, Meade TW, Peart S, Brennan PJ, Mann AH. Is there any evidence for a protective effect of anti-thrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. BMJ 1997; 62:269-72.","journal-title":"BMJ"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun, M.J.; Namboodiri, M.M.; CW, Jr, Heath","year":"1991","unstructured":"Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl 7 Med 1991;325:1593-6.","journal-title":"N Engl 7 Med"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/jnci\/85.11.912","article-title":"Reduced risk of large-bowel adenomas among aspirin users. The polyp prevention study group","volume":"85","author":"Greenberg, E.R.; Baron, J.A.; DH, Jr, Freeman","year":"1993","unstructured":"Greenberg ER, Baron JA, Freeman DH Jr. Reduced risk of large-bowel adenomas among aspirin users. The polyp prevention study group. Nad Cancer Inst 1993;85:912-6.","journal-title":"Nad Cancer Inst"},{"key":"ref_54","first-page":"655","article-title":"Aspirin and the risk of colorectal cancer in women","volume":"333","author":"Giovannucci, E.; Egan, K.M.; Hunter, D.","year":"1995","unstructured":"Giovannucci E, Egan KM, Hunter D, et al. Aspirin and the risk of colorectal cancer in women. NEnglJMed 1995;333:655-7.","journal-title":"NEnglJMed"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/excr.1996.0023","article-title":"Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adencarcinoma cells: effect of cell cycle and apoptosis","volume":"222","author":"Shiff, S.J.; Koutsos, M.I.; Qiao, L.; Rigas, B.","year":"1996","unstructured":"Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adencarcinoma cells: effect of cell cycle and apoptosis. Exp Cell Res 1996;222: 179-88.","journal-title":"Exp Cell Res"},{"key":"ref_56","first-page":"151","article-title":"Relationship between aldose reductase inhibiting activity and anticataract action of various non-steroidal antiinflammatory drugs","volume-title":"cataracts in the population and influencing factors developements in ophthalmology","author":"Gupta, S.K.; Joshi, S.","year":"1991","unstructured":"Gupta SK, Joshi S. Relationship between aldose reductase inhibiting activity and anticataract action of various non-steroidal antiinflammatory drugs. In: Sasaki K, Hockwin 0, eds, Distribution of cataracts in the population and influencing factors developements in ophthalmology. Basle: Karger, 1991; pp 151-6."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(94)90740-4","article-title":"Fibroblast growth-promoting activity in proliferation vitroutinopathy: antagonism by acetylsalicylic acid","volume":"262","author":"Kahler, C.M.; Kieselbach, G.F.; Reinisch, N.; Troger, J.; Gottinger, W.; Weidermann, C.J.","year":"1994","unstructured":"Kahler CM, Kieselbach GF, Reinisch N, Troger J, Gottinger W, Weidermann CJ. Fibroblast growth-promoting activity in proliferation vitroutinopathy: antagonism by acetylsalicylic acid. EurJ Pharm 1994;262:261-9.","journal-title":"EurJ Pharm"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jech.38.3.259","article-title":"The Caerphilly and Speedwell Collaborative Group. Caerphilly and Speedwell Collaborative Heart Disease Studies","volume":"38","year":"1984","unstructured":"The Caerphilly and Speedwell Collaborative Group. Caerphilly and Speedwell Collaborative Heart Disease Studies. J Epidemiol Comm Health 1984;38:259-62.","journal-title":"J Epidemiol Comm Health"},{"key":"ref_59","article-title":"In: New perspectives on aspirin therapy 1982","author":"Fryers, G.","year":"1982","unstructured":"Fryers G. In: New perspectives on aspirin therapy 1982. New Orleans: Aspirin Foundation Symposia, April 1982."},{"key":"ref_60","article-title":"Entstehungsgseschichte bekannter Heilmittel","author":"Hecht, G.","year":"1935","unstructured":"Hecht G. Entstehungsgseschichte bekannter Heilmittel. Das Aspirin. Munch Med Wochenschr 1935;538.","journal-title":"Das Aspirin. Munch Med Wochenschr"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/74\/876\/587\/50222386\/postgradmedj-74-587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/74\/876\/587\/50222386\/postgradmedj-74-587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T14:58:52Z","timestamp":1683903532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/74\/876\/587\/7059846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10,1]]},"references-count":60,"journal-issue":{"issue":"876","published-online":{"date-parts":[[1998,10,1]]},"published-print":{"date-parts":[[1998,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.74.876.587","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,10]]},"published":{"date-parts":[[1998,10,1]]}}}